Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.85 USD | +1.05% | -3.75% | -11.09% |
May. 17 | Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial | RE |
May. 02 | Transcript : Puma Biotechnology, Inc., Q1 2024 Earnings Call, May 02, 2024 |
Financials (USD)
Sales 2024 * | 219M | Sales 2025 * | 225M | Capitalization | 186M |
---|---|---|---|---|---|
Net income 2024 * | 10M | Net income 2025 * | 15M | EV / Sales 2024 * | 0.85 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.83 x |
P/E ratio 2024 * |
15.9
x | P/E ratio 2025 * |
15.8
x | Employees | 185 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.6% |
Latest transcript on Puma Biotechnology, Inc.
1 day | +1.05% | ||
1 week | -3.75% | ||
1 month | -22.22% | ||
3 months | -34.63% | ||
6 months | +2.67% | ||
Current year | -11.09% |
Managers | Title | Age | Since |
---|---|---|---|
Alan Auerbach
CEO | Chief Executive Officer | 54 | 10-09-14 |
Maximo Nougues
DFI | Director of Finance/CFO | 55 | 18-11-04 |
Alvin Wong
CTO | Chief Tech/Sci/R&D Officer | 71 | 13-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Miller
BRD | Director/Board Member | 67 | 18-02-22 |
Jay Moyes
BRD | Director/Board Member | 70 | 12-04-26 |
Alan Auerbach
CEO | Chief Executive Officer | 54 | 10-09-14 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.01% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 3.85 | +1.05% | 208,920 |
24-05-30 | 3.81 | -1.80% | 280,908 |
24-05-29 | 3.88 | -3.48% | 206,406 |
24-05-28 | 4.02 | +0.50% | 292,571 |
24-05-24 | 4 | +0.25% | 239,985 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.09% | 186M | |
+43.34% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- PBYI Stock